A growing body of research has examined the IRA’s implications for pharmaceutical innovation. Much of this literature has focused on the potential impact on the number of new drug launches, 5, 6 but ...
Morning Overview on MSN
FDA urges alternatives to animal testing in early-stage drug development
The U.S. Food and Drug Administration is actively steering drug developers away from traditional animal studies and toward ...
Early 2026 has brought a series of consequential regulatory moves from the FDA, each reflecting a common thread: the agency ...
Find out how self-driving labs utilise data-driven approaches to enhance drug discovery efficiency and innovation.
Scientists at the University of Cambridge have developed a new way to alter complex drug molecules using light rather than ...
Clinical Trials Arena on MSN
Parkinson’s research reaches “pivotal” stage, but barriers remain
Funding and clinical trial-based barriers must be addressed to ensure success on the path to developing a DMT for Parkinson’s.
Dec 11 (Reuters) - AnaptysBio (ANAB.O), opens new tab will end the development of its experimental drug to treat eczema as the treatment failed to meet the goals of a mid-stage trial, the company said ...
Drug discovery has traditionally been a reductive process—narrowing down, filtering out, and optimizing within established ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results